Stocks · News reference

TSS Q2 EPS $0.05 Misses $0.06 Estimate, Sales $35.141M Miss $47.095M Estimate

Aug 13, 2026, 8:06 PMBenzinga Newsdesk

TSS (NASDAQ:TSSI) reported quarterly earnings of $0.05 per share which missed the analyst consensus estimate of $0.06 by 16.67 percent. This is a 16.67 percent decrease over earnings of $0.06 per share from the same

Read original source More stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

TSSI

Source: benzinga
Observed: Aug 13, 2026, 8:06 PM
Checked: Aug 13, 2026, 8:06 PM
Cadence: Captured once, then retained as an archive reference
Status: fresh

Keep reading

BenzingaAug 14, 2026, 12:06 PMAvi Kapoor
Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting worse-than-expected financial results.
Read original at benzinga
AMAT ECO GEMI GLAS GLOB
BenzingaAug 14, 2026, 11:58 AMBenzinga Newsdesk
TSS shares are trading lower after the company reported worse-than-expected Q2 financial results. Also, Needham lowered its price target on the stock from $16 to $13.
Read original at benzinga
TSSI
BenzingaAug 14, 2026, 11:23 AMBenzinga Newsdesk
Needham Maintains Buy on TSS, Lowers Price Target to $13
Needham analyst Matthew Calitri maintains TSS (NASDAQ:TSSI) with a Buy and lowers the price target from $16 to $13.
Read original at benzinga
TSSI
BenzingaAug 14, 2026, 8:37 AMAvi Kapoor
Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket
Eton Pharmaceuticals Inc (NASDAQ: ETON) rose in pre-market trading after reporting strong Q2 results and issuing FY26 revenue guidance above estimates.
Read original at benzinga
AKAN AMPG BOXL BYSI BZAI

TSS Q2 EPS $0.05 Misses $0.06 Estimate, Sales $35.141M Miss $47.095M Estimate

Connected markets

Related headlines

Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

TSS shares are trading lower after the company reported worse-than-expected Q2 financial results. Also, Needham lowered its price target on the stock from $16 to $13.

Needham Maintains Buy on TSS, Lowers Price Target to $13

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket